Persistent panhypogammaglobulinemia with selected loss of memory B cells and impaired isotype expression after rituximab therapy for post-transplant EBV-associated autoimmune hemolytic anemia.
Nishio
Mitsufumi
M
Endo
Tomoyuki
T
Fujimoto
Katsuya
K
Fujimoto
Katusya
K
Sato
Norihiro
N
Sakai
Toshiya
T
Obara
Masato
M
Kumano
Koki
K
Kumano
Koti
K
Minauchi
Koichiro
K
Koike
Takao
T
D000361:Agammaglobulinemia / Q000097:blood* / Q000209:etiology; D000744:Anemia, Hemolytic, Autoimmune / Q000097:blood* / Q000150:complications / Q000821:virology; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001402:B-Lymphocytes; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D020031:Epstein-Barr Virus Infections / Q000097:blood* / Q000150:complications; D005260:Female; D004854:Herpesvirus 4, Human; D006801:Humans; D007136:Immunoglobulins / Q000097:blood; D007156:Immunologic Memory; D018655:Lymphocyte Count / Q000379:methods; D016483:Lymphoma, AIDS-Related / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab; D014184:Transplantation, Homologous; D014750:Vincristine / Q000008:administration & dosage
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007136:Immunoglobulins; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone